MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Interventions"

  • 2025 International Congress

    A mindfulness-based intervention course in pre-manifest Huntington’s disease: analysis of pilot data

    S. Berman, R. Devenyi, V. Vaughn, G. Toti, A. Lasker (Camden, USA)

    Objective: To assess feasibility and initial outcomes of a mindfulness-based intervention course in patients with pre-manifest, genetically confirmed Huntington’s disease (HD). Background: Mindfulness-based intervention courses…
  • 2025 International Congress

    Improvements in Motor and Non-Motor Symptoms of Parkinson’s Disease in Those Treated with Photobiomodulation Plus Exercise: A Sham-Controlled Study

    A. Saltmarche, O. Hares, A. Liebert, B. Bicknell, M. Naeser, G. Heller, J. Sykes, K. Togeretz, A. Namini, G. Herkes (Toronto, Canada)

    Objective: To assess efficacy of photobiomodulation + exercise to improve Parkinson’s disease (PD) symptoms. The primary outcome measure was timed up-and-go (TUG) and other motor…
  • 2025 International Congress

    Updates on Perception of Patients with Cervical Dystonia in Residents and Medical Students

    M. Patel, D. Talkington, D. Sblendorio, K. Pyle, M. Coleman, P. Sheehan, A. Memon, M. Moreno-Escobar, A. Murray, G. Pawar, J. Frey (Morgantown, USA)

    Objective: To determine if an educational intervention can reduce external stigma of patients with cervical dystonia (CD) in medical trainees. Background: Medical trainees may or…
  • 2025 International Congress

    Continuous Subcutaneous Dopaminergic Stimulation: Exploring the impact of Foslevodopa/Foscarbidopa on Gait in Parkinson’s disease.

    C. O'Keeffe, J. Inocentes, M. Bradley, A. Gallagher, F. Ruggieri, R. Walsh, T. Lynch, R. Reilly, C. Fearon (Dublin, Ireland)

    Objective: The primary objective of this study is to investigate the effect of continuous subcutaneous infusion (CSCI) of foslevodopa/foscarbidopa (FL/FC) on gait in those with…
  • 2025 International Congress

    Mind-Body Treatment For Managing Functional Weakness: A Pilot Study

    L. Tesolin, S. Calizaya, M. Lobos, M. Villar (Bolzano, Italy)

    Objective: This study evaluates the effectiveness of a group-based, treatment combining yoga, reflexotherapy, and biodanza for patients diagnosed with FMD, characterized by weakness (1). Background:…
  • 2025 International Congress

    A Four-Arm Randomized Controlled Trial on the Effects of Multi-Dimensional Cognitive Intervention in Parkinson’s Disease with Mild and Subjective Cognitive Decline (REMIND)

    P. Huang, C. Gao, YY. Tan, SD. Chen (Shanghai, China)

    Objective: To investigate the efficacy of online Brain and Body Rehab Training (BBRT) (Figure 1), a digital cognitive intervention, in Parkinson’s disease patients with mild…
  • 2025 International Congress

    Impact 360 Study for Parkinson’s Disease – a controlled phase II feasibility and safety study of a combined exercise, diet and mindfulness intervention

    J. Kelly, M. Powell, R. Cloke, J. Yu, S. Stelling, T. Watson, A. Hashimoto, A. Kuan, M. Sacheli, Y. Wang, D. Darabi, S. Appel-Cresswell (Vancouver, Canada)

    Objective: The aim of this phase II controlled trial is to evaluate the safety, feasibility, and to explore the effects of a multimodal intervention in…
  • 2025 International Congress

    Gender-Based Differences in Parkinson’s Disease Hospitalization: A Nationwide and Single Center Study

    Z. Xu, N. Bujala, A. Jain, E. Spirollari, A. Sacknovitz, A. Jiang, F. Al-Mufti, R. Fekete (New York, USA)

    Objective: To analyze hospital admission patterns among patients with Parkinson’s Disease (PD), comparing demographic characteristics, reasons for admission, length of stay, and discharge disposition between…
  • 2025 International Congress

    PARKinSOUND 2.0: The Impact of Orchestra Participation on Patients with Parkinson’s Disease

    S. Lopes, A. Ferreira, S. Gomes, C. Morgado, L. Costa, A. Goios, J. Ferreira, M. Rodrigues (Braga, Portugal)

    Objective: This study evaluates the impact of participation in a community orchestra on people with PD. Background: As interest in non-pharmacological therapies for Parkinson’s disease…
  • 2025 International Congress

    Morbidity and Mortality Associated with Aspiration Pneumonia: Nationwide Trends in Inpatient Therapy Utilization in Parkinson’s Disease Hospitalization

    T. Mehta, H. Kamo, R. Burke, M. Rem, M. Okun, C. Hess (Gainesville, USA)

    Objective: To characterize inpatient therapy utilization and the impact of aspiration pneumonia (AP) on morbidity, mortality, and outcomes in hospitalized Parkinson’s disease (PD) patients. Background:…
  • 1
  • 2
  • 3
  • …
  • 26
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley